Literature DB >> 2476082

Induction of mRNA for HLA-DR beta in human keratinocytes cocultured with interferon-gamma.

H Nilsson1, C Johansson, K Sandberg, K Funa, G V Alm, A Scheynius.   

Abstract

Explanted human keratinocytes exposed in vitro to recombinant interferon-gamma (IFN-gamma) were investigated for the appearance of mRNA for HLA-DR. Using in situ hybridization with a (35S)UTP-labelled HLA-DR beta cRNA probe, mRNA-positive cells were detected already within 6 h with maximal numbers of positive cells as well as the amount of mRNA per cell after 48 h. The corresponding protein HLA-DR, as analysed by immunoperoxidase staining, was detected on 20%-40% of the cells after 24 h and on almost all cells within 48 h. The expression of HLA-DQ and -DP antigens were always exceeded by that of HLA-DR. Whereas an increase in the concentration of IFN-gamma above 50 U/ml did not affect the maximal level of HLA-DR reactive cells, there was a fourfold increase in the frequency of cells reactive with HLA-DQ and a twofold increase for HLA-DP when the IFN-gamma concentration was raised from 50 to 500 U/ml. When IFN-gamma was withdrawn from the cultures, HLA-DR mRNA and protein synthesis ceased--indicating the continuous need for IFN-gamma to maintain the HLA-DR synthesis in keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476082     DOI: 10.1007/bf00431060

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

1.  Expression of HLA-DQ antigens on keratinocytes in Borrelia spirochete-induced skin lesions.

Authors:  U Tjernlund; A Scheynius; E Asbrink; A Hovmark
Journal:  Scand J Immunol       Date:  1986-03       Impact factor: 3.487

2.  Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.

Authors:  U Tjernlund; A Scheynius
Journal:  Scand J Immunol       Date:  1987-07       Impact factor: 3.487

3.  T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.

Authors:  U Tjernlund; A Scheynius; C Johansson; E Hagforsen; H Nilsson
Journal:  Scand J Immunol       Date:  1988-12       Impact factor: 3.487

Review 4.  Class II transplantation antigens: distribution in tissues and involvement in disease.

Authors:  U Forsum; K Claesson; E Hjelm; A Karlsson-Parra; L Klareskog; A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

5.  Signal sequences distinguish class II histocompatibility antigen beta chains of different loci.

Authors:  K Gustafsson; K Wiman; D Larhammar; L Rask; P A Peterson
Journal:  Scand J Immunol       Date:  1984-01       Impact factor: 3.487

6.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Human keratinocytes express HLA-DR antigens in the tuberculin reaction.

Authors:  A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1984-02       Impact factor: 3.487

8.  Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.

Authors:  J Auböck; D Niederwieser; N Romani; P Fritsch; C Huber
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

9.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Mutations and selection in the generation of class II histocompatibility antigen polymorphism.

Authors:  K Gustafsson; K Wiman; E Emmoth; D Larhammar; J Böhme; J J Hyldig-Nielsen; H Ronne; P A Peterson; L Rask
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.